Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study
{{output}}
Background: Elevated low-density lipoprotein cholesterol (LDL-C) after acute coronary syndrome (ACS) significantly increases cardiovascular risk. Timely reduction of LDL-C is crucial, but it takes several weeks to achieve optimal... ...
